SCHEMBL2014962

SCHEMBL2014962

COc1ccc(-c2ccc3c(c2)C(C)(C)CCC3(C)C)cc1N1CCN(CCCCCO)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RARA P10276 3/20 0.45
RARB P10826 3/20 0.45
RARG P13631 3/20 0.45
DRD2 P14416 6/20 0.43
DRD3 P35462 6/20 0.43
ADRA1A P35348 2/20 0.43
HTR1A P08908 2/20 0.43
DRD4 P21917 3/20 0.43
ADRA1D P25100 1/20 0.42
ADRA1B P35368 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
NLRP1 Q9C000 1/20 0.42
HTR7 P34969 1/20 0.42
HTR6 P50406 1/20 0.42
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12959460 1.00 RARA (0.45) RARARARBRARGDRD2DRD3
SCHEMBL2012573 0.84 RARA (0.40) RARARARBRARGDRD2DRD3
SCHEMBL12959455 0.82 RARG (0.40) RARARARBRARGDRD2DRD3
SCHEMBL2012784 0.80 KCNH2 (0.49) RARARARBRARGDRD2HTR1A
SCHEMBL2037348 0.79 KCNH2 (0.47) RARARARBRARGDRD2HTR7
SCHEMBL12633854 0.78 RARB (0.39) RARARARBRARGDRD2DRD3
SCHEMBL2014293 0.78 RARG (0.44) RARARARBRARGDRD2DRD3
SCHEMBL12633852 0.78 RARA (0.39) RARARARBRARGDRD2DRD3
SCHEMBL2014118 0.77 LRRK2 (0.42) RARARARBRARGDRD2DRD3
SCHEMBL2016394 0.77 RARG (0.45) RARARARBRARGDRD2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062015-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2015-06-23 US disclosed
US-9062015-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2015-06-23 US disclosed
US-9062015-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2015-06-23 US disclosed
EP-2513057-B1 SPHINGOSINE KINASE INHIBITORS MERCK PATENT GMBH (DE) 2013-09-04 EP disclosed
EP-2513057-B1 SPHINGOSINE KINASE INHIBITORS MERCK PATENT GMBH (DE) 2013-09-04 EP disclosed
EP-2513057-A1 SPHINGOSINE KINASE INHIBITORS Merck Patent GmbH (DE) 2012-10-24 EP disclosed
US-20120252789-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 US disclosed
US-20120252789-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 US disclosed
US-20120252789-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 US disclosed
WO-2011072791-A1 SPHINGOSINE KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-06-23 WO disclosed
WO-2011072791-A1 SPHINGOSINE KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252789-A1 INHIBITORS OF SPHINGOSINE KINASE SPHK1, SPHK2, S1PR3 RARA 4373/4885RARB 4194/4885RARG 4187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.